In search of a surrogate: engineering human beta cell lines for therapy
- PMID: 24958526
- PMCID: PMC4151247
- DOI: 10.1016/j.tem.2014.05.006
In search of a surrogate: engineering human beta cell lines for therapy
Abstract
Replacement of insulin-producing cells is a promising therapy for the restoration of the beta cell mass that is destroyed in patients with type 1 diabetes (T1D). However, the use of large amounts of islets per transplant, coupled with the scarcity of donor tissue, diminishes its feasibility. Here we briefly discuss current progress in developing ideal functional beta cells as well as the rationale for developing renewable sources of insulin-producing cells that can be transplanted.
Keywords: beta cells; embryonic stem cell; induced pluripotent stem cell; islet cell transplantation; type 1 diabetes.
Copyright © 2014. Published by Elsevier Ltd.
References
-
- Feutren G, et al. Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial. Lancet. 1986;2:119–124. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical